Learn More
Apexbio Technology LLC Saxagliptin 361442-04-8 100mg

Supplier: Apexbio Technology LLC A8650100
Saxagliptin (CAS 361442-04-8) is a small molecule developed for the management of respiratory disorders including asthma and Chronic Obstructive Pulmonary Disease It exerts its pharmacological activity by selectively inhibiting phosphodiesterase-4 (PDE4) an enzyme involved in the degradation of cyclic AMP within inflammatory cells Inhibition of PDE4 is associated with anti-inflammatory effects reducing the release of pro-inflammatory mediators implicated in airway diseases Saxagliptin is orally bioavailable and is utilized in research focused on elucidating PDE4-mediated pathways in respiratory inflammation and evaluating new therapeutic strategies for asthma and COPD
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.